Prostate Cancer - Results from #25400

Dramatic increase in prostate cancer cases by 2021 - Abstract May 11, 2011

Validation of postoperative nomograms in prostate cancer patients with long-term follow-up - Abstract May 11, 2011

PCA3 urinary test versus 1H-MRSI and DCEMR in the detection of prostate cancer foci in patients with biochemical alterations - Abstract May 11, 2011

The value and limitations of contrast-enhanced ultrasound in detection of prostate cancer - Abstract May 11, 2011

Endorectal MRI after radiation therapy: Questioning the sextant analysis - Abstract May 11, 2011

Long-term androgen ablation and docetaxel up-regulate phosphorylated Akt in castration resistant prostate cancer - Abstract May 11, 2011

EAU 2011 - Adjuvant radiotherapy leads to superior biochemical recurrence free survival compared to early salvage radiotherapy in patients with locally advanced prostate cancer: Results of a matched-controlled multi-institutional analysis - Session Highli May 11, 2011

EAU 2011 - Does biochemical progression after radical prostatectomy and adjuvant radiotherapy for locally advanced prostate cancer invariably impact cancer-specific mortality? - Session Highlights May 11, 2011

EAU 2011 - Prostate cancer associated up-regulation of AMACR, EZH2 and PSMA correlates with diminished expression of specific microRNAs - Session Highlights May 11, 2011

EAU 2011 - Androstenedione is the most efficient precursor of intraprostatic testosterone production in primary human prostate cancer tissue - Session Highlights May 11, 2011

EAU 2011 - Health-related quality of life after salvage high intensity focused ultrasound treatment (HIFU) for locally radiorecurrent prostate cancer - Session Highlights May 11, 2011

EAU 2011 - A preoperative serum biomarker panel to identify patients with prostate cancer at high risk of biochemical recurrence following radical prostatectomy - Session Highlights May 11, 2011

EAU 2011 - Serum levels of pro-inflammatory cytokines immediately increase two days after application of docetaxel in patients with castration-resistant prostate cancer and correlate with apoptosis and clinical response - Session Highlights May 11, 2011

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation - Abstract May 10, 2011

Use of complementary and alternative medicine among men with prostate cancer in a rural setting - Abstract May 10, 2011

Physicians' attitudes about shared decision making for prostate cancer screening - Abstract May 10, 2011

Evaluation of image-guidance strategies with helical tomotherapy for localised prostate cancer - Abstract May 10, 2011

Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 Study - Abstract May 10, 2011

The clinical significance of in-depth pathological assessment of extraprostatic extension and margin status in radical prostatectomies for prostate cancer - Abstract May 10, 2011

Nadir PSA level and time to PSA nadir following primary androgen deprivation therapy are the early survival predictors for prostate cancer patients with bone metastasis - Abstract May 10, 2011

Page 1271 of 1305